Dysregulation of Endothelin-1: Implications for Health Disparities in Alzheimer’s Disease
Alzheimer’s disease (AD) and related dementias disproportionately impact racial and ethnic minorities. The racial and ethnic disparities in AD could be explained by differences in cerebral vascular disease pathology. Endothelin-1 (ET-1) is a potent vasoconstrictive peptide that regulates smooth musc...
Main Author: | Donald J. Alcendor |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/10/4/199 |
Similar Items
-
Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US
by: Donald J. Alcendor
Published: (2020-07-01) -
Addressing Disparities in Alzheimer's Disease and African-American Participation in Research: An Asset-Based Community Development Approach
by: Gina Green-Harris, et al.
Published: (2019-05-01) -
Disseminating Health Disparities Education Through Tele-Learning
by: LaSonya Knowles, et al.
Published: (2008-08-01) -
Gender Disparities in Anti-dementia Medication Use among Older Adults: Health Equity Considerations and Management of Alzheimer's Disease and Related Dementias
by: Z. Kevin Lu, et al.
Published: (2021-08-01) -
Interactions between Amyloid-Β Proteins and Human Brain Pericytes: Implications for the Pathobiology of Alzheimer’s Disease
by: Donald J. Alcendor
Published: (2020-05-01)